Cytidine diphosphate-13C9,15N3 (dilithium)

Cytidine diphosphate-13C9,15N3 (dilithium)

• UNSPSC Description: Cytidine diphosphate-13C9,15N3 dilithium is 13C and 15N-labeled Cytidine diphosphate (HY-113400). Cytidine diphosphate is a nucleoside diphosphate that acts as a carrier for phosphorylcholine, diacylglycerol, and other molecules during phospholipid synthesis.
• Target Antigen: Endogenous Metabolite; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Metabolic Enzyme/Protease;Others
• Applications: Metabolism-protein/nucleotide metabolism
• Field of Research: Others
• Assay Protocol: https://www.medchemexpress.com/cytidine-diphosphate-13c9-15n3-dilithium.html
• Solubility: 10 mM in DMSO
• Smiles: O[13C@H]1[13C@@H](O)[13C@H]([15N]2[13CH]=[13CH][13C]([15NH2])=[15N][13C]2=O)O[13C@@H]1[13CH2]OP(OP(O[Li])(O[Li])=O)(O)=O
• Molecular Weight: 426.96
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Method of treating cancer with nucleotide therapeutics. US20220249534 A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported